Eden vs Embody: Which GLP — 2026 Pricing, Plans, and Verdict

Last reviewed: September 1, 2026 Last updated: September 1, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Eden charges $198/month for semaglutide and $298/month for tirzepatide, structured as two recurring charges: medication plus a required $99/month membership. Embody charges $299/month for semaglutide and $349/month for tirzepatide as a single flat rate with no separate membership. Over 12 months on semaglutide, Eden costs $2,376 versus Embody's $3,588—a $1,212 annual difference. On tirzepatide the gap narrows: Eden's $3,576 versus Embody's $4,188, a $612 annual difference. Both offer cancel-anytime month-to-month plans, injection-only formats, and money-back guarantees, but the billing structure and service inclusions differ. Eden's lower headline depends on accepting a recurring membership charge; Embody's higher flat rate includes unlimited provider visits and 24/7 clinical chat without a separate membership tier.

At-a-glance comparison

*Full guarantee conditions not documented in sources; confirm complete terms at checkout. Pricing verified Eden 2026-07-19, Embody 2026-07-21.

Normalized month-to-month pricing

Both providers offer cancel-anytime monthly plans with no long-term commitment, making them directly comparable on an ongoing basis. The key structural difference: Eden separates medication and membership into two recurring charges, while Embody bundles everything into a single monthly rate.

Eden all-in monthly costs

• Semaglutide: $99 medication + $99 membership = $198/month all-in (verified 2026-07-19)
• Tirzepatide: $199 medication + $99 membership = $298/month all-in (verified 2026-07-19)

Eden's $99 medication-only figure cannot stand alone—the membership is required to access the program. The all-in cost is $198 or $298 depending on compound.

Embody flat-rate monthly costs

• Semaglutide: $299/month (verified 2026-07-21)
• Tirzepatide: $349/month (verified 2026-07-21)

Embody publishes a single flat rate that includes medication, provider visits, and clinical support with no separate membership tier. Our sources document only month-to-month rates; multi-month tiers are not published for Embody.

Monthly cost difference

• Semaglutide: Embody costs $101/month more than Eden ($299 vs $198)
• Tirzepatide: Embody costs $51/month more than Eden ($349 vs $298)

12-month cost comparison

Annualized costs assume continued month-to-month enrollment with no plan changes. These figures are our calculation based on the verified monthly rates above.

Semaglutide:

• Eden: $198 × 12 = $2,376/year
• Embody: $299 × 12 = $3,588/year
• Difference: $1,212/year more for Embody

Tirzepatide:

• Eden: $298 × 12 = $3,576/year
• Embody: $349 × 12 = $4,188/year
• Difference: $612/year more for Embody

The cost gap is wider on semaglutide ($1,212 annually) than on tirzepatide ($612 annually) because tirzepatide's medication cost at Eden is $100 higher while the membership remains $99, narrowing the relative difference.

Decision factors: billing structure and service model

Eden's two-charge membership model

Eden structures its program as medication plus membership. The $99 membership is required and recurs monthly alongside the medication charge. This model produces a lower all-in cost than Embody—$198 for semaglutide and $298 for tirzepatide—but requires managing two separate recurring charges. Membership terms state "cancel anytime," and the checkout flow indicates no charge until medical approval within 24 hours. Eden offers a money-back guarantee tied to achieving 10% weight loss in six months on compounded plans, though full guarantee conditions are not documented in our sources.

Embody's flat-rate bundled model

Embody charges a single monthly rate—$299 for semaglutide, $349 for tirzepatide—that includes medication, unlimited provider visits, and 24/7 clinical chat support. There is no separate membership tier or secondary charge. The higher headline reflects a bundled service model rather than unbundled components. Embody also offers a six-month satisfaction refund, though complete terms are not documented. The single-charge structure may simplify budgeting despite the higher cost.

What the cost difference buys

The $101/month premium on semaglutide (or $51/month on tirzepatide) at Embody reflects the difference between a bundled flat-rate model and Eden's membership-plus-medication structure. Both providers include clinical support—Eden's through the membership, Embody's explicitly as unlimited visits and 24/7 chat. The documented evidence does not detail whether the scope of support differs; confirm specific visit policies, chat availability, and dosing adjustment protocols during intake if ongoing clinical access is a priority.

Guarantees and refund policies

Both providers advertise money-back guarantees, but the structures differ. Eden's guarantee is outcome-based: lose 10% body weight in six months or receive a refund. Embody's is satisfaction-based: a six-month refund if unsatisfied. Neither source documents the complete terms—such as adherence requirements, refund calculation method, or exclusions—so confirm these policies at checkout if the guarantee influences your decision.

Medication formats and flexibility

Both providers offered injection-only formats in the documented flows captured in July 2026. Neither source shows oral or alternative delivery options. If you require or prefer an oral capsule format, confirm current availability directly with each provider before committing.

Choose Eden if…

• You prioritize the lowest monthly cost and are comfortable with a two-charge billing structure (medication plus membership)
• The $198 semaglutide all-in rate or $298 tirzepatide all-in rate fits your budget better than Embody's $299/$349 flat rates
• You want an outcome-based guarantee tied to a specific weight-loss threshold (10% in six months)
• You prefer flexibility to cancel month-to-month without long-term commitment
• Injection delivery is acceptable for your treatment plan

Choose Embody if…

• You prefer a single flat monthly rate with no separate membership charge, even at a higher cost
• Unlimited provider visits and 24/7 clinical chat are important to you and you want those inclusions explicitly stated
• You value a satisfaction-based refund policy over an outcome-based guarantee
• Simpler billing (one charge rather than two) is worth the $51–$101/month premium
• You want cancel-anytime flexibility without navigating a membership tier

Where PlexusDx fits

PlexusDx charges $189/month for compounded semaglutide injection (month-to-month) and $289/month for compounded tirzepatide injection (month-to-month), with no separate membership fee. These rates sit between Eden's $198/$298 and Embody's $299/$349. PlexusDx also offers lower committed-term rates: semaglutide drops to $169/month prepaid over three months or $149/month prepaid over six months; tirzepatide drops to $269/month prepaid over three months or $249/month prepaid over six months (these are per-month equivalents for prepaid totals, our calculation). Neither Eden nor Embody publish committed-term pricing in our documented sources.

PlexusDx includes oral capsule options (compounded semaglutide oral at $289 month-to-month, compounded tirzepatide oral at $349 month-to-month, with similar committed-term rates available) and a microdose semaglutide injection protocol at $129/month for maintenance or cautious titration. One all-inclusive price covers the provider visit, prescription, medication, and shipping with no membership tier. If you want route flexibility, committed-term savings, or a microdose entry point, PlexusDx expands your options beyond Eden's and Embody's injection-only monthly structures.

Methodology and freshness

This comparison uses standard ongoing month-to-month rates only, verified at the dates shown. We captured Eden's pricing and terms on 2026-07-19 and Embody's on 2026-07-21. All figures reflect regular published rates or required recurring charges as they appeared at checkout or on public product pages. The 12-month cost calculations are our own, derived by multiplying verified monthly rates by 12. We do not publish multi-month prepaid rates for Embody because those figures were not available in our documented sources under our evidence rules. Eden offers monthly plans only in the captured data. PlexusDx pricing reflects our own standard and committed-term rates as of 2026-09-01.

Money-back guarantee headlines are documented as they appeared on each provider's site, but complete terms—including adherence requirements, refund calculation, and exclusions—are not captured. Confirm all guarantee conditions, cancellation policies, visit limits, and clinical support scope during your intake or at checkout. Pricing and policies may change after the capture dates; verify current rates and terms directly with each provider before committing.

Frequently Asked Questions

Does Eden's $99 medication-only price include everything I need?

No. Eden's $99 figure is the medication cost only. A required $99/month membership must be added, making the all-in cost $198/month for semaglutide or $298/month for tirzepatide. The membership recurs monthly as a separate charge and is necessary to access the program.

Does Embody offer multi-month plans or lower committed-term rates?

Our sources document only Embody's month-to-month rates ($299 semaglutide, $349 tirzepatide). Multi-month tiers are not published in the verified evidence we use for this comparison. Contact Embody directly if you want to explore longer-term commitment options that may not appear in standard public rate cards.

How do the money-back guarantees compare between Eden and Embody?

Eden advertises a guarantee tied to losing 10% body weight in six months; Embody offers a six-month satisfaction refund. Neither source documents the complete terms—such as adherence requirements or how refunds are calculated. Confirm full guarantee conditions, including any exclusions or compliance expectations, at checkout before relying on these policies.

Can I switch from semaglutide to tirzepatide mid-treatment with either provider?

Both providers offer compounded semaglutide and tirzepatide injections, suggesting compound switching is possible, but our sources do not detail the process, timing, or any fees associated with changing compounds. Ask during intake or contact support directly to understand how mid-treatment compound changes are handled and whether any price adjustment or re-approval is required.

Why is PlexusDx included in an Eden-vs-Embody comparison?

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs. Our pricing sits between Eden's and Embody's on month-to-month semaglutide and tirzepatide injections, and we offer oral capsule options and committed-term rates that neither competitor publishes. Including PlexusDx lets you see a third transparent option in the same decision framework.

Sources

• Eden pricing, terms, and membership structure (captured 2026-07-19)
• Embody pricing, guarantee, clinical support, and cancellation terms (captured 2026-07-21)
• Provider comparison table cross-reference (captured 2026-07-17 to 2026-07-23)
• PlexusDx pricing and product portfolio (internal data, 2026-09-01)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.